Search

everythinglearnresearchcommunity

for

Search:↓

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

Gefitinib can cause hair loss without scarring.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

GLP-1 receptor agonists can both help and harm hair, so careful monitoring is needed.

Licorice root-derived nanoparticles target liver cancer cells to improve treatment and reduce side effects.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

3α‐OH‐DHP is essential for reducing nerve activity related to blood pressure control during pregnancy.

Isoginkgetin reduces inflammation in cells by blocking NF-κB activation.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Some gonadal hormone drugs can block filovirus entry into cells.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

HNG helps hair grow by keeping hair in the growth phase longer.

Some drugs for inflammation may cause psoriasis-like hair loss.